# Technical Performance Assessment of Tc-99m Tetrofosmin for Differentiation of Recurrence vs Radiation Necrosis in Patients With Glioma

> **NCT02971319** · PHASE2 · COMPLETED · sponsor: **Proactina S.A.** · enrollment: 32 (actual)

## Conditions studied

- Glioma (Diagnosis)

## Interventions

- **DEVICE:** Tc-99M-Tetrofosmin SPECT
- **DEVICE:** F-18 FDG PET

## Key facts

- **NCT ID:** NCT02971319
- **Lead sponsor:** Proactina S.A.
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2016-09
- **Primary completion:** 2017-11-17
- **Final completion:** 2017-12-17
- **Target enrollment:** 32 (ACTUAL)
- **Last updated:** 2018-01-26

## Collaborators

- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02971319

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02971319, "Technical Performance Assessment of Tc-99m Tetrofosmin for Differentiation of Recurrence vs Radiation Necrosis in Patients With Glioma". Retrieved via AI Analytics 2026-06-14 from https://api.ai-analytics.org/clinical/NCT02971319. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*